APA

Cramer J. P., Dubischar K., Eder S., Burchard G. D., Jelinek T., Jilma B., Kollaritsch H., Reisinger E. & Westritschnig K. (20171113). Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study. : Vaccine.

Chicago

Cramer Jakob P, Dubischar Katrin, Eder Susanne, Burchard Gerd D, Jelinek Tomas, Jilma Bernd, Kollaritsch Herwig, Reisinger Emil and Westritschnig Kerstin. 20171113. Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study. : Vaccine.

Harvard

Cramer J. P., Dubischar K., Eder S., Burchard G. D., Jelinek T., Jilma B., Kollaritsch H., Reisinger E. and Westritschnig K. (20171113). Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study. : Vaccine.

MLA

Cramer Jakob P, Dubischar Katrin, Eder Susanne, Burchard Gerd D, Jelinek Tomas, Jilma Bernd, Kollaritsch Herwig, Reisinger Emil and Westritschnig Kerstin. Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study. : Vaccine. 20171113.